Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2021 / Cilt: 27 - Sayı: 2

Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?

Pages
175–180
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In infants with extremely low birth weight, unnecessary closure treatment can be prevented by closely monitoring the symptoms of patent ductus arteriosus and performing echocardiography when necessary.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Hemodynamically significant patent ductus arteriosus is resulting in severe mortality and morbidity in infants with extremely low birth weight.
📊
Key Findings & Data:In our study, we aimed to evaluate the necessity of performing routine echocardiography in the first 72 hours in extremely low birth weight infants.
💡
Conclusion & Impact:In infants with extremely low birth weight, unnecessary closure treatment can be prevented by closely monitoring the symptoms of patent ductus arteriosus and performing echocardiography when necessary.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Hemodynamically significant patent ductus arteriosus is resulting in severe mortality and morbidity in infants with extremely low birth weight. In our study, we aimed to evaluate the necessity of performing routine echocardiography in the first 72 hours in extremely low birth weight infants. STUDY DESIGN: This study was planned retrospectively. Between June 2016 and December 2018, 36 patients diagnosed with hemodynamically significant patent ductus arteriosus who were hospitalized in the neonatal intensive care unit, with ≤28 gestational weeks or ≤1000g were included in this study. These babies were routinely performed echocardiography for patent ductus arteriosus between 24-72 hours, although they were asymptomatic in the period from June 2016 to December 2017 (n=23). Between January 2018 and December 2018, patients without patent ductus arteriosus symptoms were expected to complete 72 hours for routine patent ductus arteriosus screening (n=13). The patients were divided into 2 groups as the early echocardiography group (n=23) and the late echocardiography group (n=13). In the presence of at least one of the clinical signs of systemic hypo perfusion and/or pulmonary hyper perfusion, symptomatic patent ductus arteriosus was accepted and closure treatment was applied with ibuprofen (n=23) or paracetamol (n=5). While the two groups were compared in terms of demographic features, echocardiography findings, and the state of taking closure therapy, patients receiving closure therapy were compared in terms of mortality and premature morbidity. RESULTS: The mean birth weight of 36 patients was 855±241 g, and the mean gestational age was 26.4±2.1 gestational weeks. It was observed that the two groups were similar in terms of demographic characteristics. Although the findings of echocardiography and treatment rates were similar between the two groups, it was observed that the echocardiography group had earlier closure treatment (p=0.03). In patients receiving closure treatment, performing early (n=17) and late (n=11) echocardiography showed no statistical difference in the long-term results. CONCLUSION: Performing early echocardiography without symptoms in infants with extremely low birth weight may provoke the clinician to give patent ductus arteriosus closure treatment earlier. In infants with extremely low birth weight, unnecessary closure treatment can be prevented by closely monitoring the symptoms of patent ductus arteriosus and performing echocardiography when necessary.

🔖

Cite This Article

ÖZDEMİR, S. A., KULALI, F., ERGON, E. Y., KALKANLI, O. H., ÇOLAK, R., YILDIRIM, T. G., ÇALKAVUR, Ş., YILMAZER, M. M., ZİHNİ, C. (2022). Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 27 - Sayı: 2, 175–180. https://ajindex.com/articles/525821

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. 2018;19(7):e394- e402. Doi: 10.1542/neo.19-7-e394
  2. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1):e138-44. Doi: 10.1542/peds. 2008-2418
  3. Havranek T, Rahimi M, Hall H, Armbrecht E. Feeding preterm neonates with patent ductus arteriosus (PDA): intestinal blood flow characteristics and clinical outcomes. J Matern Fetal Neonatal Med. 2015;28(5):52630. Doi: 10.3109/14767058.2014.923395
  4. Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol. 2012;32(5):344-8. Doi: 10.1038/jp.2011.102
  5. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed. 1996;75(3):183-6. Doi: 10.1136/fn.75.3.f183
  6. Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99-F104. Doi: 10.1136/archdischild-2013- 304695
  7. Benitz WE; Committee on Fetus and Newborn, American Academy of Pediatrics. Pediatrics. 2016;137(1): e20153730. Doi: 10.1542/peds.2015-3730
  8. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117(4):1113-21. Doi: 10.1542/peds.2005-1528
  9. Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018;53(Suppl 1):S76-S87. Doi: 10.5152/TurkPediatriArs.2018.01808
  10. Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S et al. PDA-TOLERATE (PDA: TO LEave it alone or Respond And Treat Early) Trial Investigators. PDA-TOLERATE Trial: An exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr. 2019;205:41- 48.e6. Doi: 10.1016/j.jpeds.2018.09.012
  11. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr. 2011;100(2):231-5. Doi: 10.1111/j.1651-2227.2010. 02027.x
  12. Oncel MY, Erdeve O. Oral medicat